Related Articles

• Amgen’s platelet treatment wins FDA support
• An Agency in Crisis
• Biosimilars: U.S. Presidential Candidates Pledge Support
• California Healthcare Institute Supports Introduction of Biosimilars Legislation
• Decision Makes It Tougher to Sue Medical Device Makers
• Drug Trial Oversight Needs U.S. Probe, Lawmakers Say
• Editorial: Complexity of Biotech Drugs Means Copying Them is Risky
• EU, U.S. regulators ease process for orphan drugs
• FDA adding 1,300 to regulation staff
• FDA Advisors Declare 'FDA Science and Mission at Risk'
• FDA Approves Avastin to Treat Breast Cancer
• FDA Chief Writes Congress for Money
• FDA Decision on Cancer Drug Expected Today
• FDA Expects to Open Offices in China
• FDA May Support New Testing Method for Drugs
• FDA Rule May Protect Firms From Disclosure Lawsuits
• FDA Safety Concerns Slowing Future Innovation
• FDA to Aid Tropical Disease Research
• FDA Will Review CV Therapeutics' Ranexa for Possible New Use
• Genzyme Launches Kidney Disease Drug
• Member Company BioMarin Develops Treatment for Rare Disease
• New Breast Cancer Diagnostic Tests Introduced
• New Drug Ruling May Confuse Investors
• Senate and FDA respond to recent food and drug safety issues
• Some Small Biotechs May Gain from Generics Law
• White House Wants to Increase FDA Authority Over Imports